Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia M. Bassetti, E.M. Trecarichi, A. Mesini, T. Spanu, D.R. Giacobbe, M. Rossi, E. Shenone, G.D. Pascale, M.P. Molinari, R. Cauda, C. Viscoli, M. Tumbarello Clinical Microbiology and Infection Volume 18, Issue 9, Pages 862-869 (September 2012) DOI: 10.1111/j.1469-0691.2011.03679.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 1 Inadequate initial antimicrobial treatment (%). Rates of inadequate initial antimicrobial treatment in patients with community-acquired (CA), healthcare-associated >48 h (HCA >48 h) and healthcare-associated <48 h (HCA <48 h) Staphylococcus aureus bacteraemia (SAB) according to methicillin resistance. MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-resistant S. aureus. Clinical Microbiology and Infection 2012 18, 862-869DOI: (10.1111/j.1469-0691.2011.03679.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions